Reata Pharmaceuticals Inc. (RETA) Fundamentals

Reata Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapeutics to address serious and life-threatening diseases by targeting molecular pathways. The company's product in the pipeline include bardoxolone methyl; Omaveloxolone and others.
SHARE INFORMATION
Market Cap$ 1,009,295,397
Shares Outstanding36,462,984
Float20,298,920
Percent Float55.67%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 11,489,000
Latest Fiscal EPS$ -8.18
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions440
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months4,110,188
Institutional Holdings Percent137.0%
Institutional Sold Previous 3 Months6,471,081
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months519,532
Insider Holdings Percent1.1
Insider Sold Previous 3 Months-
Insider Shares Owned386,742
TRADING INFO
52 Week High$ 153.41
52 Week Low$ 20.24
52 Week High Change$ -73.03
21 Day Moving Average$ 25.8981
21 Day Extended Moving Average$ 26.6901
50 Day Moving Average$ 30.894
50 Day Extended Moving Average$ 29.3253
200 Day Moving Average$ 60.5469
200 Day Extended Moving Average$ 55.3611
10 Day Average Volume550,044
20 Day Average Volume513,118
30 Day Average Volume496,681
50 Day Average Volume651,881
Alpha0.026680
Beta1.2528
Standard Deviation0.303140
R20.038275
7 Day Price Change$ 5.06
7 Day Percent Change22.37%
21 Day Price Change$ 1.27
21 Day Percent Change4.81%
30 Day Price Change$ -3.88
30 Day Percent Change-12.29%
Month to Date Price Change$ 2.30
Month to Date Percent Change9.06%
Quarter to Date Price Change$ -5.08
Quarter to Date Percent Change-15.51%
180 Day Price Change$ -62.07
180 Day Percent Change-69.16%
200 Day Price Change$ -68.33
200 Day Percent Change-71.17%
Year to Date Price Change$ 1.31
Year to Date Percent Change4.97%

Reata Pharmaceuticals Inc. (RETA) Key Ratios

PROFITABILITY
EBIT Margin-2,213.7%
EBITDA Margin-2,202.9%
Pre-Tax Profit Margin-2,693.6%
Profit Margin Count0.0%
Gross Margin100.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 11,459,000
Revenue Per Share$ 0.3633
Revenue (3 Years)$ -28.18
Revenue (5 Years)$ -30.57
FINANCIAL STRENGTH
Price to Tangible Book7.80
Total Debt To Equity1.10
Int Coverage-5.00
Current Ratio12.30
Leverage Ratio3.30
Quick Ratio12.20
Long Term Debt To Capital0.52
VALUATION MEASURES
PE Ratio-3.30
Enterprise Value$ 600,671,904
Price to Sales76.1961
Price to Free Cash-4.00
PE High Last 5 Years-20.90
Price To Book7.80
Price To Cash Flow0.00
PE Low Last 5 Years-64.30
Price to Tangible Book7.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.10
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-41.91
Return on Equity-127.49
Return on Capital-64.94

Reata Pharmaceuticals Inc. (RETA) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOJ. Warren Huff
Emplyoees349
Last AuditUQ
CIK0001358762
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address5320 Legacy Drive
Plano, TX 75024
Websitehttps://www.reatapharma.com
Facsimile-
Telephone+1 972 865-2219
Emailir@reatapharma.com


Your Recent History
NASDAQ
RETA
Reata Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.